Virtue, TestCard and ExSeed join Novartis & Wayra UK health tech accelerator
Pharma giant Novartis and O2 innovation arm Wayra UK revealed last week that Virtue, TestCard and ExSeed would join its nine-month Health Hub accelerator programme.The nine-month programme is designed to help entrepreneurs addressing pressing health and care challenges scale their businesses. London-based digital therapeutics startup Virtue made headlines last year with its LookBack digital therapy platform, which uses VR to help those affected by dementia. During the nine-month programme, Novartis will provide the startups with access to its network and support with NHS engagement. Wayra UK will offer, among others, mentoring, business development support and help to raise funds.
#virtual reality